International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline

18F-FDG PET/CT benchmark lymphoma total metabolic tumor volume

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 15 03 2024
accepted: 21 06 2024
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 1 8 2024
Statut: aheadofprint

Résumé

Total metabolic tumor volume (TMTV) is prognostic in lymphoma. However, cutoff values for risk stratification vary markedly, according to the tumor delineation method used. We aimed to create a standardized TMTV benchmark dataset allowing TMTV to be tested and applied as a reproducible biomarker.

Identifiants

DOI: 10.2967/jnumed.124.267789 PMID: 39089812
pubmed: 39089812
pii: jnumed.124.267789
doi: 10.2967/jnumed.124.267789
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Ronald Boellaard (R)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands; r.boellaard@amsterdamumc.nl.

Irène Buvat (I)

LITO, Inserm, Institut Curie, Orsay, France.

Christophe Nioche (C)

LITO, Inserm, Institut Curie, Orsay, France.

Luca Ceriani (L)

Clinic of Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland; and EOC, Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland.

Anne-Ségolène Cottereau (AS)

Department of Nuclear Medicine, Cochin Hospital, APHP; and Faculté de Médecine, Université Paris Cité, Paris, France.

Luca Guerra (L)

Nuclear Medicine Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.

Rodney J Hicks (RJ)

Department of Medicine, St. Vincent's Hospital Medical School, University of Melbourne, Melbourne, Victoria, Australia.

Salim Kanoun (S)

Centre de Recherche Clinique de Toulouse, Team 9, Toulouse, France.

Carsten Kobe (C)

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Annika Loft (A)

PET & Cyclotron Unit 3982, Copenhagen University Hospital, Copenhagen, Denmark.

Heiko Schöder (H)

Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Annibale Versari (A)

Nuclear Medicine Department, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.

Conrad-Amadeus Voltin (CA)

Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Gerben J C Zwezerijnen (GJC)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Josée M Zijlstra (JM)

Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.

N George Mikhaeel (NG)

Department of Clinical Oncology, Guy's Cancer Centre and School of Cancer and Pharmaceutical Sciences, King's College London University, London, United Kingdom.

Andrea Gallamini (A)

Research and Innovation Department, Antoine Lacassagne Cancer Center, Nice, France.

Tarec C El-Galaly (TC)

Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
Department of Hematology, Odense University Hospital, Odense, Denmark.

Christine Hanoun (C)

Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Stephane Chauvie (S)

Medical Physics Division, Santa Croce e Carle Hospital, Cuneo, Italy.

Romain Ricci (R)

LYSARC, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.

Emanuele Zucca (E)

Oncology Institute of Southern Switzerland; and EOC, Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland; and.

Michel Meignan (M)

Department of Nuclear Medicine, Cochin Hospital, APHP; and Faculté de Médecine, Université Paris Cité, Paris, France.

Sally F Barrington (SF)

King's College London and Guy's and St. Thomas's PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Classifications MeSH